Persano and coworkers [22] found that BMP2 was not only an effective prodifferentiation treatment for GBM-derived stem cells but also that the BMP2-mediated differentiation made the tumor cells more sensitive to Temozolomide (TMZ) treatment. Here, BMP2 is linked to glioblastoma.